• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER GMBH LOCKING SCREW, FULLY THREADED T2 TIBIA Ø5X55 MM; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER GMBH LOCKING SCREW, FULLY THREADED T2 TIBIA Ø5X55 MM; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES Back to Search Results
Catalog Number 18965055S
Medical Device Problem Codes Break (1069); Fracture (1260)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 12/06/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Based on the available information the device will not be returned therefore an evaluation of the device cannot be performed.Should additional information become available, it will be provided in a supplemental report.
 
Event or Problem Description
As reported by the customer, "breakage of the distal screws of the femoral nail".
 
Additional Manufacturer Narrative
Please note correction to d9/h3.The reported event could be confirmed, since the screw is broken as reported.The device inspection revealed the following: the visual inspection has shown that the locking screw is broken apart.Both fragments of the screw were returned for evaluation.During the microscopic inspection the typical characteristics of a fatigue fracture could be identified on the fracture face.There is a fatigue zone with a smooth surface and progression lines over almost the whole surface which ends in an instantaneous zone, where the screw finally broke apart.There are impression marks at the screw thread visible, these marks indicate that the screw was exposed to high loads while it was implanted.A review of the device history for the reported lot did not indicate any abnormalities.No corrective actions are required at this time.A review of the labeling did not indicate any abnormalities.No indications of material, manufacturing or design related problems were found during the investigation.No product related issue could be detected.There was no additional information about the event provided, no x-rays and no information about patient history or activity was available.Therefore the root cause of the breakage cannot be defined.The evaluation of the plate has shown that fatigue did lead to the breakage of the device.Based on the available information were the implants implanted in march 2022 and the event date was in december 2023, in this relation following statement of the the gamma3 instructions for use (l22000066 rev ab, 01-2022) can be mentioned: "the lifetime for internal fixation devices is defined by their function in the human body.Internal fixation devices for osteosynthesis are intended to keep bone fragments/segments in a correct anatomical position until reliable bone consolidation is achieved.It must be considered that these devices are developed based upon the available scientific knowledge at the time of design and manufacture.The current scientific literature on the time the fracture takes to heal, as related to the gamma3 implants or to the identified similar benchmark devices / state-of-the-art, is limited.However, the individual values reported in 18 separate data sources range from an average of 2.2 to 14.5 months (median = 3.4 months; iqr = 1.4 months) for endpoints related to time to union / healing.These devices are not intended to have a permanent function.It is known from the clinical literature that if bone consolidation is not achieved, these fracture fixation devices may fail and require removal.This risk of implant failure is dependent on numerous individual factors, including but not limited to a patient¿s pre-existing medical conditions, gender, age, body weight, bone quality, patient activity, and other variables.The interaction between implant and body ends only with the complete removal of the implant.The removal of these internal fixation devices after bone consolidation has been achieved is not mandatory.The licensed healthcare professional must always weigh the risks of an implant removal against its benefits for the individual patient." if more information is provided, the case will be reassessed.
 
Event or Problem Description
As reported by the customer, "breakage of the distal screws of the femoral nail".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LOCKING SCREW, FULLY THREADED T2 TIBIA Ø5X55 MM
Common Device Name
ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES
Manufacturer (Section D)
STRYKER GMBH
bohnackerweg 1
postfach
selzach 2545
SZ  2545
Manufacturer (Section G)
STRYKER TRAUMA KIEL
prof. kuentscher-strasse 1-5
schoenkirchen/kiel D-242 32
GM   D-24232
Manufacturer Contact
anna jusinski
325 corporate drive
mahwah, NJ 07430
2018315000
MDR Report Key18516526
Report Number0009610622-2024-00033
Device Sequence Number12659312
Product Code HSB
UDI-Device Identifier04546540202529
UDI-Public04546540202529
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K203819
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date (Section B) 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date04/30/2026
Device Catalogue Number18965055S
Device Lot NumberK01CCB3
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/22/2023
Supplement Date Received by Manufacturer02/29/2024
Initial Report FDA Received Date01/16/2024
Supplement Report FDA Received Date03/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/20/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient SexUnknown
-
-